Amgen Gets FDA Nod for Arthritis Drug Dosage - TheStreet

Amgen Gets FDA Nod for Arthritis Drug Dosage

The FDA approves a once-weekly dosage of the arthritis drug Enbrel.
Author:
Publish date:

Amgen

(AMGN) - Get Report

and

Wyeth Pharmaceuticals

said Monday that the Food and Drug Administration has approved a once-weekly dosage of the arthritis drug Enbrel.

Enbrel is approved to treat moderate to severe active rheumatoid arthritis in patients with psoriatic arthritis and active ankylosing spondylitis, the company said.

Wyeth Pharmaceuticals is a division of

Wyeth

(WYE)

.